Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University, discusses the potential impact the Trump administration will have on Medicaid programs.
Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University, discusses the potential impact the Trump administration will have on Medicaid programs.
Transcript
What impact do you think the Trump administration’s willingness to provide waivers to states for their Medicaid programs could have on healthcare outcomes?
I think that the discussion that we are having now about how to make public health care financing better and stronger. This is a discussion that has been going on for as long as we’ve had public health insurance programs. We are now in the sixth decade of that. I don’t think that the administration initiative as they are framed now are being advanced to continue a long discussion about how to improve the performance of these programs. I think the administration made clear from the first day it took office that the Medicaid program originally was not intended to insure low-income people who were not connected to cash welfare. Nonetheless, it has evolved into that.
Now, it’s our public insurance program and the question is how to make it work better, how to create new options for using alternative approaches to public insurance that would look and feel maybe more like Medicare advance plans where Medicare buys from the private sector which we already do this in Medicaid. Expand the options, look for areas of efficiency in long term service and support. And I should note it’s about how we can support people who are poor and depend on Medicaid who need work supports and a job. But it’s not about creating circumstances where people are made to feel they are liable to lose something for no reason of their own. I don’t see that as the way to go. I also think that the discussion we need to have is around how to build support for work into Medicaid expansions not how to use the work demonstrations to roll back benefits.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More